0.1407
price down icon45.39%   -0.2219
 
loading
전일 마감가:
$0.3626
열려 있는:
$0.149
하루 거래량:
114.49K
Relative Volume:
400.01
시가총액:
$N/A
수익:
$7.33M
순이익/손실:
$-21.20M
주가수익비율:
-0.1539
EPS:
-0.9143
순현금흐름:
$-12.68M
1주 성능:
-45.39%
1개월 성능:
-86.71%
6개월 성능:
-95.33%
1년 성능:
-96.64%
1일 변동 폭
Value
$0.1407
$0.149
1주일 범위
Value
$0.149
$0.149
52주 변동 폭
Value
$0.149
$0.149

프로페이즈 Stock (PRPH) Company Profile

Name
명칭
Prophase Labs Inc
Name
전화
-
Name
주소
-
Name
직원
0
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
PRPH's Discussions on Twitter

Compare PRPH vs TMO, DHR, IDXX, A, WAT

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Diagnostics & Research icon
PRPH
Prophase Labs Inc
0.147 0 7.33M -21.20M -12.68M -0.9143
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
488.93 184.15B 44.56B 6.72B 6.29B 17.74
Diagnostics & Research icon
DHR
Danaher Corp
192.90 137.93B 24.57B 3.60B 5.26B 5.051
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
591.19 47.82B 4.30B 1.06B 1.04B 13.08
Diagnostics & Research icon
A
Agilent Technologies Inc
113.54 32.62B 7.07B 1.29B 993.00M 4.5355
Diagnostics & Research icon
WAT
Waters Corp
294.67 29.19B 3.17B 642.63M 516.49M 10.77

프로페이즈 Stock (PRPH) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2021-12-20 개시 H.C. Wainwright Buy
2021-10-13 다운그레이드 Dawson James Buy → Neutral
2021-01-20 개시 Dawson James Buy

프로페이즈 주식(PRPH)의 최신 뉴스

pulisher
Mar 11, 2026

Aug Swings: How correlated is ProPhase Labs Inc to the S P500Earnings Overview Summary & Verified Short-Term Plans - baoquankhu1.vn

Mar 11, 2026
pulisher
Mar 06, 2026

Short Covering: What analysts say about ProPhase Labs Inc stockVolume Spike & Long-Term Investment Growth Plans - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 06, 2026

Guidance Update: Whats next for ProPhase Labs Inc stockJuly 2025 Final Week & Precise Buy Zone Identification - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 05, 2026

Will ProPhase Labs Inc outperform the market in YEAR2025 AllTime Highs & Low Risk Entry Point Guides - baoquankhu1.vn

Mar 05, 2026
pulisher
Feb 13, 2026

ProPhase Labs Hosts Investor Webinar on Growth Portfolio - TipRanks

Feb 13, 2026
pulisher
Feb 02, 2026

Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on February 3rd - The Manila Times

Feb 02, 2026
pulisher
Jan 27, 2026

ProPhase Labs Provides Update on COVID-19 Receivables - TradingView

Jan 27, 2026
pulisher
Jan 26, 2026

ProPhase Labs (PRPH) Provides Update on COVID-19 Receivables Col - GuruFocus

Jan 26, 2026
pulisher
Jan 26, 2026

ProPhase Labs Provides Crown Medical Collections Update; 250+ Insurance Payors Engaged, Approximately 50 Matters in Advanced Settlement Posture - ChartMill

Jan 26, 2026
pulisher
Jan 24, 2026

ProPhase Labs Secures Funding and Completes Market Transition Following Reverse Stock Split - AD HOC NEWS

Jan 24, 2026
pulisher
Jan 23, 2026

ProPhase Labs Announces Uplisting to OTCID Market - TipRanks

Jan 23, 2026
pulisher
Jan 22, 2026

ProPhase Labs (PRPH) Uplisted to OTC Market - GuruFocus

Jan 22, 2026
pulisher
Jan 10, 2026

Prophase Labs Approves Strategic Proposals at Special Meeting - MSN

Jan 10, 2026
pulisher
Jan 09, 2026

ProPhase Labs, Inc.Common Stock (NQ: PRPH - FinancialContent

Jan 09, 2026
pulisher
Jan 09, 2026

ProPhase Labs Updates Shareholders Amid Volatility and OTC Move - TipRanks

Jan 09, 2026
pulisher
Jan 09, 2026

ProPhase Labs Announces Immediate Resignation of Board Member - TipRanks

Jan 09, 2026
pulisher
Jan 09, 2026

ProPhase Labs Announces Board Resignation - TradingView — Track All Markets

Jan 09, 2026
pulisher
Jan 09, 2026

Is ProPhase Labs Inc. stock a safe haven asset2025 Pullback Review & Weekly Watchlist of Top Performers - ulpravda.ru

Jan 09, 2026
pulisher
Jan 08, 2026

How ProPhase Labs Inc. stock compares to market leadersCEO Change & Low Drawdown Trading Techniques - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

How strong is ProPhase Labs Inc. stock balance sheetLayoff News & Community Verified Trade Signals - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Will ProPhase Labs Inc. stock outperform Nasdaq indexEarnings Overview Report & AI Driven Stock Reports - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

MSN Money - MSN

Jan 08, 2026
pulisher
Jan 07, 2026

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Jan 07, 2026
pulisher
Jan 07, 2026

Total liabilities of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets

Jan 07, 2026
pulisher
Jan 07, 2026

Diluted earnings per share (diluted EPS) of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets

Jan 07, 2026
pulisher
Jan 07, 2026

Cash from investing activities of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets

Jan 07, 2026
pulisher
Jan 06, 2026

ProPhase Labs faces NASDAQ delisting, plans appeal, OTC move - MSN

Jan 06, 2026
pulisher
Jan 06, 2026

ProPhase Labs, Inc.(NasdaqCM: PRPH) dropped from S&P TMI Index - marketscreener.com

Jan 06, 2026
pulisher
Jan 06, 2026

ProPhase Labs, Inc. Balance Sheet – OTC:PRPH - TradingView — Track All Markets

Jan 06, 2026
pulisher
Jan 06, 2026

Free cash flow per share of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets

Jan 06, 2026
pulisher
Jan 06, 2026

Long term debt to total assets ratio of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets

Jan 06, 2026
pulisher
Jan 06, 2026

Net margin % of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets

Jan 06, 2026
pulisher
Jan 06, 2026

Price to cash flow ratio of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets

Jan 06, 2026
pulisher
Jan 06, 2026

Debt to equity ratio of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets

Jan 06, 2026
pulisher
Jan 06, 2026

Enterprise value to EBITDA ratio of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets

Jan 06, 2026
pulisher
Jan 06, 2026

Net current asset value per share of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets

Jan 06, 2026
pulisher
Jan 06, 2026

Total debt per share of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets

Jan 06, 2026
pulisher
Jan 06, 2026

EBITDA margin % of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets

Jan 06, 2026
pulisher
Jan 06, 2026

Long term debt to total equity ratio of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets

Jan 06, 2026
pulisher
Jan 06, 2026

Operating cash flow per share of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets

Jan 06, 2026
pulisher
Jan 06, 2026

Net income of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets

Jan 06, 2026
pulisher
Jan 06, 2026

ProPhase Labs, Inc. Statistics – OTC:PRPH - TradingView — Track All Markets

Jan 06, 2026
pulisher
Jan 06, 2026

ProPhase Labs, Inc. Income Statement – OTC:PRPH - TradingView — Track All Markets

Jan 06, 2026
pulisher
Jan 06, 2026

Price to earnings ratio of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets

Jan 06, 2026
pulisher
Jan 06, 2026

ProPhase Labs, Inc. Financial Statements – OTC:PRPH - TradingView — Track All Markets

Jan 06, 2026
pulisher
Jan 06, 2026

ProPhase Labs, Inc. Earnings and Revenue – OTC:PRPH - TradingView — Track All Markets

Jan 06, 2026
pulisher
Jan 06, 2026

ProPhase Labs, Inc. Revenue Breakdown – OTC:PRPH - TradingView — Track All Markets

Jan 06, 2026
pulisher
Jan 06, 2026

Basic earnings per share (basic EPS) of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets

Jan 06, 2026
pulisher
Jan 06, 2026

Free float of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets

Jan 06, 2026
pulisher
Jan 05, 2026

How one lab swapped $3.3M of debt for shares, jolting its stock price - Stock Titan

Jan 05, 2026
pulisher
Jan 02, 2026

ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2024 Earnings Call Transcript - MSN

Jan 02, 2026

프로페이즈 (PRPH) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
diagnostics_research DGX
$200.03
price down icon 0.42%
diagnostics_research LH
$268.03
price down icon 0.71%
diagnostics_research MTD
$1,210.58
price down icon 1.01%
$193.28
price down icon 1.85%
diagnostics_research IQV
$168.04
price down icon 1.26%
diagnostics_research WAT
$293.07
price down icon 1.60%
자본화:     |  볼륨(24시간):